Align Financial Statements From 2010 to 2025
| AFW Stock | EUR 161.05 2.80 1.71% |
Check Align Technology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Align Technology's main balance sheet or income statement drivers, such as , as well as many indicators such as . Align financial statements analysis is a perfect complement when working with Align Technology Valuation or Volatility modules.
Align |
Align Technology Company Current Valuation Analysis
Align Technology's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Align Technology Current Valuation | 13.59 B |
Most of Align Technology's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Align Technology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Align Technology has a Current Valuation of 13.59 B. This is 5.37% lower than that of the Healthcare sector and 9.4% higher than that of the Medical Devices industry. The current valuation for all Germany stocks is 18.24% higher than that of the company.
Align Technology Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Align Technology's current stock value. Our valuation model uses many indicators to compare Align Technology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Align Technology competition to find correlations between indicators driving Align Technology's intrinsic value. More Info.Align Technology is rated below average in return on equity category among its peers. It is rated fifth in return on asset category among its peers reporting about 0.69 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Align Technology is roughly 1.45 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Align Technology's earnings, one of the primary drivers of an investment's value.About Align Technology Financial Statements
Align Technology stakeholders use historical fundamental indicators, such as Align Technology's revenue or net income, to determine how well the company is positioned to perform in the future. Although Align Technology investors may analyze each financial statement separately, they are all interrelated. For example, changes in Align Technology's assets and liabilities are reflected in the revenues and expenses on Align Technology's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Align Technology. Please read more on our technical analysis and fundamental analysis pages.
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontics, and restorative and aesthetic dentistry worldwide. The company was founded in 1997 and is headquartered in San Jose, California. ALIGN TECHNOLOGY operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 11660 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Align Stock
When determining whether Align Technology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Align Technology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Align Technology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Align Technology Stock:Check out the analysis of Align Technology Correlation against competitors. For more detail on how to invest in Align Stock please use our How to Invest in Align Technology guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.